Getein Biotech Inc Cash Flow-to-Debt Ratio
Getein Biotech Inc cash flow-to-debt ratio. Getein Biotech Inc (603387) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥100.90 Million could theoretically repay 0% of its total liabilities (CN¥1.04 Billion) in one year. Check earnings quality score of Getein Biotech Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Getein Biotech Inc (2012–2025)
Cash flow-to-debt ratio of Getein Biotech Inc from 2012 to 2025. Historical debt coverage capacity for Getein Biotech Inc across 14 annual periods. Check 603387 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Getein Biotech Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Getein Biotech Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Getein Biotech Inc. For the full cash flow conversion analysis, see Getein Biotech Inc (603387) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | CN¥392.59 Million | CN¥896.55 Million | ▲ +2.1% |
| 2024 | 0.43x | CN¥423.00 Million | CN¥986.42 Million | ▲ +32.6% |
| 2023 | 0.32x | CN¥333.22 Million | CN¥1.03 Billion | ▼ -32.2% |
| 2022 | 0.48x | CN¥482.96 Million | CN¥1.01 Billion | ▼ -4.7% |
| 2021 | 0.50x | CN¥432.36 Million | CN¥863.90 Million | ▲ +87.8% |
| 2020 | 0.27x | CN¥185.47 Million | CN¥695.95 Million | ▼ -61.5% |
| 2019 | 0.69x | CN¥225.73 Million | CN¥325.98 Million | ▼ -30.7% |
| 2018 | 1.00x | CN¥187.10 Million | CN¥187.23 Million | ▼ -38.1% |
| 2017 | 1.61x | CN¥191.91 Million | CN¥118.87 Million | ▼ -5.6% |
| 2016 | 1.71x | CN¥155.91 Million | CN¥91.13 Million | ▼ -16.4% |
| 2015 | 2.05x | CN¥121.73 Million | CN¥59.48 Million | ▼ -14.3% |
| 2014 | 2.39x | CN¥98.53 Million | CN¥41.26 Million | ▲ +181.6% |
| 2013 | 0.85x | CN¥59.72 Million | CN¥70.42 Million | ▲ +75.1% |
| 2012 | 0.48x | CN¥23.80 Million | CN¥49.15 Million | — |